Laura Kirton

Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): an open-label, randomised, phase 3 trial

Bernadette Brennan, Laura Kirton, Perrine Marec‐Bérard et al. · The Lancet · 2022 · 105 citations · Full text

Surgical Oncology, Ewing Sarcoma, Medicine +7

Comparison of two chemotherapy regimens in Ewing sarcoma (ES): Overall and subgroup results of the Euro Ewing 2012 randomized trial (EE2012).

Bernadette Brennan, Laura Kirton, Perrine Marec‐Bérard et al. · Journal of Clinical Oncology · 2020 · 50 citations

Subgroup Results, Surgical Oncology, Cancer Management +18

Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).

Martin G. McCabe, Laura Kirton, Maria Khan et al. · Journal of Clinical Oncology · 2020 · 43 citations · Full text

Surgical Oncology, Five-year Survival, International Randomized +15

Phase III assessment of topotecan and cyclophosphamide and high-dose ifosfamide in rEECur: An international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).

Martin G. McCabe, Laura Kirton, Maria Khan et al. · Journal of Clinical Oncology · 2022 · 38 citations

Surgical Oncology, Cancer Management, Lba2 Background +16

COVID-19 in children with haematological malignancies

Gerard Millen, Roland Arnold, Jean‐Baptiste Cazier et al. · Archives of Disease in Childhood · 2021 · 27 citations · Full text